Recent CFIUS legislation has had significant effects on the range of transactions and investments that are potentially subject to regulatory review. Navigating the review process can be a daunting task, and it appears that CFIUS is moving quickly and proactively to stop risky deals from closing. Although CFIUS is largely a voluntary process, recent mandatory filing requirements have modified the criteria that triggers a mandatory filing. Should companies be concerned about CFIUS stepping up their investigations into non-notified transactions, or deals that were closed without a filing? What types of transactions are subject to a mandatory review? What sectors will be impacted under the new TID (technology, infrastructure, and data) rules?
Also, Presidential administration changes have historically brought uncertainty to the M&A market. How will the Biden administration’s approach shift the United States’ openness to foreign direct investment? What countries will attract more scrutiny? What key risk areas will dealmakers need to be aware of when evaluating investment structures and the timing needed to close a deal?
Nancy Fischer leads the law firm’s Public Practices and Public Policy teams and is recognized as an authority on international trade law.
Fill out the form to reach our team regarding your inquiries related to Registration, Sales/Sponsorship, Speaking, and Press. You can also subscribe to the Events Newsletter to keep up-to-date with The Deal Events.
A series of discussions for healthcare dealmakers on the current opportunities, pitfalls and latest developments in the M&A market.
Experts discuss trends in the tech M&A market including virtual dealmaking, the proliferation of SPACs, stock sell-off and cross border deals.